Carl Zeiss Meditec AG provided earnings guidance for the full year of fiscal 2021. The Company expects revenue and EBIT to continue to recover over the further course of fiscal year 2020/21 compared with the prior year, which was markedly dominated by the COVID-19 pandemic.